GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
This study will determine the effectiveness of MK0777 GEM versus Lorazepam in the treatment of patients with generalized anxiety disorder. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
Epistemonikos ID: 64c59c9c66a8db0cc511378975186c263046257f
First added on: May 04, 2024